Ascend Wellness Stock Down 6.8 % Shares of OTC:AAWH opened at $0.47 on Friday. Ascend Wellness has a 12-month low of $0.42 and a 12-month high of $1.82. The stock’s 50-day moving average price ...

Winning Gold at The Drum Awards for Agency Business in the Leadership Team category is Archetype Ascend. Here's how, in its own words, its initiative to support BIPOC execs took off. How did ...

"We founded Ascend with a vision to quilt together the best operators and technologies within the advanced manufacturing field. The complementary services at ABL and Ascend will further strengthen ...

Ascend Wellness Holdings Llc Class A ( (AAWH)) has released its Q3 earnings. Here is a breakdown of the information Ascend Wellness Holdings Llc Class A presented to its investors. Ascend Wellness ...

Vertical Integration: Achieved 52% AWH penetration for the full quarter. Ascend Wellness Holdings Inc (AAWH) plans to reduce expenditures by $30 million in 2025 through cost-saving initiatives.

The new program will be called Autism Support Center for Executive Functioning and Neurodiversity (ASCEND) which will connect students with other students and campus resources that will ensure ...

Ascend Wellness reported Q3 revenue amounted to $141.6 million, up 0.3% year-over-year and 0.1% quarter-over-quarter. Q3 net loss was $28.3 million, compared to a net loss of $11.2 million in the ...

Ascend Wellness Holdings (AWH) discussed its third-quarter financial performance and strategic initiatives during its earnings call, emphasizing a plan to optimize assets and reduce costs by $30 ...

Brownsville Ascend Charter School is a charter school located in Brooklyn, NY, which is in a large city setting. The student population of Brownsville Ascend Charter School is 871 and the school ...

Uplift Ascend is a charter school located in Fort Worth, TX, which is in a large city setting. The student population of Uplift Ascend is 920 and the school serves PK-5. At Uplift Ascend ...

In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Ascendis Pharma (ASND – Research Report), with a price target of $153.00. Yaron Werber has given his Buy rating ...

On Friday, Citi adjusted its stance on Ascendis Pharma (NASDAQ:ASND) shares, reducing the price target to $200 from the previous $207. The firm retained a Buy rating on the stock despite the ...